BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34907588)

  • 1. Adherence to colonoscopy in cascade screening of colorectal cancer: A systematic review and meta-analysis.
    Wu W; Huang J; Yang Y; Gu K; Luu HN; Tan S; Yang C; Fu J; Bao P; Ying T; Withers M; Mao D; Chen S; Gong Y; Wong MCS; Xu W
    J Gastroenterol Hepatol; 2022 Apr; 37(4):620-631. PubMed ID: 34907588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis.
    Zhang J; Cheng Z; Ma Y; He C; Lu Y; Zhao Y; Chang X; Zhang Y; Bai Y; Cheng N
    Clin Colorectal Cancer; 2017 Dec; 16(4):252-263. PubMed ID: 28687458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Perdue LA; Henrikson NB; Bean SI; Blasi PR
    JAMA; 2021 May; 325(19):1978-1998. PubMed ID: 34003220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.
    Niedermaier T; Weigl K; Hoffmeister M; Brenner H
    Eur J Epidemiol; 2017 Jun; 32(6):481-493. PubMed ID: 28667446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A global view of adherence to colonoscopy follow-up in cascade screening of colorectal cancer.
    Yang Y; Huang J; Wu W; Luu HN; Moy FM; Tan S; Fu J; Ying T; Withers M; Hung DT; Mao D; Chen S; Wong MCS; Xu W
    Eur J Cancer Care (Engl); 2022 Sep; 31(5):e13577. PubMed ID: 35315165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of risk assessment and fecal immunochemical test in colorectal cancer screening: Results from a population-based program and meta-analysis.
    Wang Z; Teng J; Wu W; Dou J; Wong MCS; Gong Y; Huang J; Gu K; Xu W
    Cancer Med; 2023 Sep; 12(17):18189-18200. PubMed ID: 37578430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
    Meklin J; SyrjÄnen K; Eskelinen M
    Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
    de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
    Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis.
    Elmunzer BJ; Singal AG; Sussman JB; Deshpande AR; Sussman DA; Conte ML; Dwamena BA; Rogers MA; Schoenfeld PS; Inadomi JM; Saini SD; Waljee AK
    Gastrointest Endosc; 2015 Mar; 81(3):700-709.e3. PubMed ID: 25708757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of bleeding and perforation from sigmoidoscopy or colonoscopy in colorectal cancer screening: A systematic review and meta-analyses.
    Kindt IS; Martiny FHJ; Gram EG; Bie AKL; Jauernik CP; Rahbek OJ; Nielsen SB; Siersma V; Bang CW; Brodersen JB
    PLoS One; 2023; 18(10):e0292797. PubMed ID: 37906565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis.
    Jodal HC; Helsingen LM; Anderson JC; Lytvyn L; Vandvik PO; Emilsson L
    BMJ Open; 2019 Oct; 9(10):e032773. PubMed ID: 31578199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for colon cancer: A test for occult blood.
    Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
    Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: modeling the impact on colonoscopy requirements and cancer detection rates.
    Olynyk JK; Platell CF; Collett JA
    J Gastroenterol Hepatol; 2001 Apr; 16(4):389-92. PubMed ID: 11354276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis.
    Ding H; Lin J; Xu Z; Wang HHX; Huang L; Huang J; Wong MCS
    BMC Cancer; 2024 Mar; 24(1):365. PubMed ID: 38515013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L; Paszat LF
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Piper MA; Perdue LA; Rutter CM; Webber EM; O'Connor E; Smith N; Whitlock EP
    JAMA; 2016 Jun; 315(23):2576-94. PubMed ID: 27305422
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.